Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
gilead sciences
immuno-oncology
2
×
kite pharma
kymriah
life sciences
medicare
2
×
national blog main
national top stories
san francisco
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
yescarta
acquisition
adaptimmune
allergan
allogeneic
alnylam
approval
bidding
bill newell
biobucks
biological
blueprint
boulder/denver blog main
boulder/denver top stories
brad loncar
brent saunders
bristol-myers squibb
buyout
calistoga pharmaceuticals
car-t
car-t immunotherapy
celgene
checkpoint inhibitors
clinical study
What
adding
airport
annual
apocalypse
beds
bets
boost
cancer
celgene
days
drug
expensive
fallout
far
gilead
gone
home
j.p
jpm
million
notes
paying
pipeline
price
program
sciences
sleep
staggers
startup
startup's
tango
tap
therapeutics
time
tiny
vortex
Language
Current search:
immuno-oncology
×
medicare
×
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
